Pay-for-performance, and its ultimate embodiment, value-based purchasing, have become common in developed world health systems as a method to encourage delivery of better quality and more appropriate care. The effectiveness of these approaches, however, is yet to be clearly demonstrated by the research. (NBER Paper) A new paper from the National Bureau of Economic Research examines the application of these programs to middle and low-income countries. The authors focus on four key issues, what to reward, who to reward, how to reward and identification and avoidance of undesirable and unintended consequences of initiating a pay-for-performance program. They note that many lower income countries have poor health care workforces and that the hope is that pay-for-performance can create rapid improvement. They go on, however, to address concerns about whether the programs are being properly designed in light of the current state of the research on the key issues they raise, and they further discuss the inadequacies of the research in helping to create an optimum design. The paper is a helpful reprise of general issues regarding these programs and a warning about two quickly taking developed country approaches, which may not even be working in those countries, to less-developed nations.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
What do you get when you combine a company with a commodity business model, that out of desperation massively overpays for another company that has a commodity business model? $10...
July 27, 2022
The “stupid” model for health care venture capital investing is alive and well. Everside health, which operates primary care clinics and has grown by acquiring other failing health care businesses,...
July 26, 2022
Apparently not even a cute name can save you if you have a stupid business. I constantly bemoan the mis-application of capital and health care is Exhibit A. Olive, another...
July 26, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace